MedPath

Sonivie, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

6

Active:3
Completed:0

Trial Phases

1 Phases

Not Applicable:6

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials

Not Applicable
6 (100.0%)

THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension

Not Applicable
Recruiting
Conditions
Hypertension
First Posted Date
2024-08-19
Last Posted Date
2025-03-20
Lead Sponsor
SoniVie Inc.
Target Recruit Count
261
Registration Number
NCT06559891
Locations
🇺🇸

Cardiology, PC, Birmingham, Alabama, United States

🇺🇸

Honor Health Research Institue, Scottsdale, Arizona, United States

🇺🇸

Cardiology Associates Research Group, Jonesboro, Arkansas, United States

and more 12 locations

REDUCED 1 - Renal Denervation Using Ultrasonic Catheter EmitteD Energy Study /

Not Applicable
Active, not recruiting
Conditions
Uncontrolled Stage 2 Hypertension
First Posted Date
2022-05-13
Last Posted Date
2024-02-07
Lead Sponsor
SoniVie Inc.
Target Recruit Count
25
Registration Number
NCT05372679
Locations
🇺🇸

Cardiology P.C., Birmingham, Alabama, United States

🇺🇸

ST Bernards Medical Center, Jonesboro, Arkansas, United States

🇺🇸

Arkansas Heart Hospital, Little Rock, Arkansas, United States

and more 6 locations

TROPHY PAH Pivotal Study - TReatment of Pulmonary HYpertension for PAH Pivotal Study

Not Applicable
Not yet recruiting
Conditions
Pulmonary Arterial Hypertension
First Posted Date
2020-09-30
Last Posted Date
2022-04-01
Lead Sponsor
SoniVie Inc.
Target Recruit Count
205
Registration Number
NCT04570228

TReatment of Pulmonary Hypertension Group II Study

Not Applicable
Active, not recruiting
Conditions
Pulmonary Hypertension (PH) Due to Left Heart Disease
First Posted Date
2018-08-02
Last Posted Date
2023-08-21
Lead Sponsor
SoniVie Inc.
Target Recruit Count
15
Registration Number
NCT03611270
Locations
🇺🇸

UC San Diego Medical Center, San Diego, California, United States

🇺🇸

University of California, San Francisco Medical Center, San Francisco, California, United States

🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

TReatment Of Pulmonary HYpertension 1-US Study

Not Applicable
Active, not recruiting
Conditions
Pulmonary Arterial Hypertension
First Posted Date
2016-07-18
Last Posted Date
2023-08-21
Lead Sponsor
SoniVie Inc.
Target Recruit Count
15
Registration Number
NCT02835950
Locations
🇺🇸

UC San Diego Health, San Diego, California, United States

🇺🇸

University of Michigan, Ann Arbor, Michigan, United States

🇺🇸

Columbia University Medical Center/NewYork Presbyterian Hospital, New York, New York, United States

and more 1 locations
  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.